Sign in

Waystar Holding (WAY)

Earnings summaries and quarterly performance for Waystar Holding.

Research analysts who have asked questions during Waystar Holding earnings calls.

Adam Hotchkiss

Goldman Sachs

4 questions for WAY

Also covers: ALKT, ALRM, BL +12 more

Elizabeth Anderson

Evercore ISI

4 questions for WAY

Also covers: AGL, ALGN, CAH +23 more

Richard Close

Canaccord Genuity Group

4 questions for WAY

Also covers: ACCD, AHCO, CLOV +15 more

Allen Lutz

Bank of America

3 questions for WAY

Also covers: ACCD, CAH, COR +14 more

Brian Peterson

Raymond James Financial

3 questions for WAY

Also covers: BIGC, BLKB, BOX +18 more

George Hill

Deutsche Bank

3 questions for WAY

Also covers: AGL, CAH, CI +16 more

Ryan Daniels

William Blair & Company, L.L.C.

3 questions for WAY

Also covers: ACCD, AGL, ALHC +12 more

Anne McCormick

JPMorgan Chase & Co.

2 questions for WAY

Also covers: DOCS, HCAT, HQY +4 more

Jailendra Singh

Truist Securities

2 questions for WAY

Also covers: ACCD, AGL, AMWL +16 more

Saket Kalia

Barclays Capital

2 questions for WAY

Also covers: ADBE, ADSK, ALRM +24 more

Alex L. Gogelov

JPMorgan Chase & Co.

1 question for WAY

Anne Samuel

JPMorgan Chase & Co.

1 question for WAY

Also covers: DOCS, EVH, HQY +3 more

Brian Tanquilut

Jefferies

1 question for WAY

Also covers: ACHC, ADUS, AHCO +29 more

Charles Rhyee

TD Cowen

1 question for WAY

Also covers: AMWL, BTSG, CAH +18 more

Daniel Grosslight

Citigroup

1 question for WAY

Also covers: AGL, CAH, COR +12 more

Jared Haase

William Blair & Company

1 question for WAY

Also covers: ADUS, ALHC, DH +9 more

Johnathan McCary

Raymond James

1 question for WAY

Also covers: DH, DOCS, INTA +2 more

Liz Lee

Deutsche Bank

1 question for WAY

Also covers: EHTH

Sean Dodge

RBC Capital Markets

1 question for WAY

Also covers: CDMO, CTLT, EVH +10 more

Stephanie Davis

Barclays

1 question for WAY

Also covers: ACCD, CAH, COR +20 more

Steven Valiquette

Mizuho

1 question for WAY

Also covers: ALGN, CAH, COR +12 more

Recent press releases and 8-K filings for WAY.

Waystar CFO Discusses Growth Drivers, AI Strategy, and Market Dynamics at Citi Conference
WAY
Guidance Update
Product Launch
M&A
  • Waystar's core business helps healthcare providers ensure efficient payment, achieving a 99% first pass clean claim rate and differentiating through a platform approach that demonstrates clear ROI.
  • The company's revenue is split approximately 50% subscription and 50% volume-based, benefiting from strong utilization observed over the past five to six quarters.
  • Generative AI solutions have delivered significant results, with clients reporting a 70% decrease in time for prior authorizations and a 90% decrease in time for denials and appeals management, with monetization through price increases and new SKUs.
  • The $1.25 billion acquisition of Iodine strategically expanded Waystar into clinical documentation, integrating over 160 AI models to enhance claim accuracy.
  • Waystar maintains long-term targets of low double-digit revenue growth, 40%+ Adjusted EBITDA margins, and 70%+ free cash flow conversion, alongside an annual deleveraging goal of one turn.
1 day ago
Waystar Discusses Strategic Acquisitions, AI Product Impact, and Financial Outlook
WAY
M&A
Product Launch
Guidance Update
  • Waystar acquired Iodine for $1.25 billion, integrating its 160+ AI modules to enhance clinical documentation and advance its "perfect undeniable claim" vision.
  • New generative AI products, part of the Altitude suite, are showing strong results, with clients reporting a 70% decrease in prior authorization time and a 90% decrease in denials and appeals management time, contributing to a growing portion of the company's pipeline and bookings.
  • The company's revenue mix is approximately 50% subscription and 50% volume-based, with a strong net revenue retention rate of 108-110%, supported by 97% gross revenue retention and 3-4% annual price increases.
  • Waystar differentiates itself through its platform approach, demonstrated ROI, a database of over 6 billion annual transactions for AI learning, and extensive connectivity with over 500 EHR/practice management systems and thousands of payers.
  • For FY 2025, the guide implies an 8% year-over-year standalone growth rate in Q4, with long-term targets including low double-digit revenue growth, 40%+ adjusted EBITDA margins, and 70%+ free cash flow conversion.
1 day ago
Waystar Discusses Platform Strategy, AI Integration, and Financial Outlook at Citi Conference
WAY
M&A
Product Launch
Guidance Update
  • Waystar's core business focuses on helping healthcare providers efficiently capture revenue, achieving a 99% first pass clean claim rate for its clients, significantly higher than the national average denial rate of 16-17%.
  • The company's $1.25 billion acquisition of Iodine has expanded its platform into clinical documentation, integrating over 160 AI models to convert unstructured clinical notes into structured information for claims and improve prior authorizations.
  • Waystar's generative AI solutions have demonstrated substantial efficiency gains, including a 70% decrease in time for prior authorizations and a 90% decrease in time for denials and appeals management.
  • The revenue mix is approximately 50% subscription and 50% volume-based, with the company reporting strong utilization over the past five to six quarters. Waystar targets low double-digit revenue growth and a net revenue retention rate of 108-110%.
  • Waystar maintains a competitive advantage through its large database of over 6 billion annual transactions for AI model training and extensive connectivity with over 500 EHR/practice management systems and thousands of payers.
1 day ago
Waystar Reports Strong Q3 2025 Results and Raises Full-Year Guidance Following Iodine Acquisition
WAY
Earnings
Guidance Update
M&A
  • Waystar reported strong Q3 2025 financial results, with revenue growing 12% year-over-year to $269 million and adjusted EBITDA increasing 17% year-over-year to $113 million, achieving a 42% adjusted EBITDA margin.
  • The company completed the acquisition of Iodine Software on October 1, which is expected to expand its total addressable market by over 15% and contribute approximately $30 million in revenue in Q4 2025.
  • Waystar raised its full-year 2025 guidance, with revenue now expected to be between $1,085 million and $1,093 million (midpoint $1,089 million) and adjusted EBITDA between $451 million and $455 million (midpoint $453 million), reflecting a 15% year-over-year revenue growth rate and an adjusted EBITDA margin of approximately 42%.
  • The company's net revenue retention rate was 113% for the last 12 months, and unleveraged free cash flow for Q3 2025 was $96 million.
Oct 29, 2025, 8:30 PM
Waystar Reports Strong Q3 2025 Results, Completes Iodine Software Acquisition, and Raises Full-Year Guidance
WAY
Earnings
M&A
Guidance Update
  • Waystar reported strong financial results for Q3 2025, with revenue growing 12% year-over-year to $269 million and an adjusted EBITDA margin of 42%.
  • The company completed the acquisition of Iodine Software on October 1, which expands its total addressable market by more than 15% and adds nearly 150 health systems to its client base.
  • Waystar raised its full-year 2025 guidance, projecting revenue between $1,085 million and $1,093 million (midpoint $1,089 million) and adjusted EBITDA between $451 million and $455 million (midpoint $453 million), with an expected 42% adjusted EBITDA margin.
  • The Net Revenue Retention Rate (NRR) was 113% for the last 12 months, and the number of clients generating over $100,000 in trailing 12-month revenue increased 11% year-over-year to 1,306 in Q3.
Oct 29, 2025, 8:30 PM
Waystar reports strong Q3 2025 results, completes Iodine Software acquisition, and raises full-year guidance
WAY
Earnings
Guidance Update
M&A
  • Waystar achieved $269 million in revenue for Q3 2025, representing 12% year-over-year growth, and an adjusted EBITDA of $113 million, resulting in a 42% adjusted EBITDA margin.
  • The company completed the acquisition of Iodine Software on October 1, 2025, which is expected to expand its total addressable market by more than 15% and accelerate its product roadmap by nearly two years.
  • Client metrics remained robust, with a Net Revenue Retention Rate of 113% for the last 12 months and an 11% year-over-year increase in clients generating over $100,000 in trailing 12-month revenue, reaching 1,306 in Q3 2025.
  • Waystar raised its full-year 2025 guidance, projecting revenue between $1,085 million and $1,093 million (midpoint $1,089 million) and adjusted EBITDA between $451 million and $455 million (midpoint $453 million), with an expected adjusted EBITDA margin of approximately 42%.
Oct 29, 2025, 8:30 PM
Waystar Reports Strong Q3 2025 Performance and Raises FY25 Guidance
WAY
Earnings
Guidance Update
M&A
  • Waystar reported strong Q3 2025 performance, with 12% revenue growth and 17% Adjusted EBITDA growth compared to Q3 2024, achieving an Adjusted EBITDA margin of 42%.
  • The company generated $96 million in unlevered free cash flow for Q3 2025.
  • For the twelve months ended September 30, 2025, Waystar saw 11% year-over-year growth in clients with over $100,000 in TTM revenue and a net revenue retention rate of 113%.
  • Waystar raised its FY 2025 guidance midpoints, projecting revenue of $1,089 million and Adjusted EBITDA of $453 million, which includes $30 million in revenue and $12 million in Adjusted EBITDA from the lodine Software acquisition for one full quarter.
Oct 29, 2025, 8:30 PM
Waystar Holding Corp. Reports Strong Q3 2025 Results and Raises Full-Year Guidance
WAY
Earnings
Guidance Update
Revenue Acceleration/Inflection
  • Waystar Holding Corp. reported Q3 2025 revenue of $268.7 million, representing a 12% year-over-year increase.
  • For Q3 2025, the company achieved net income of $30.6 million and non-GAAP net income of $67.8 million, alongside an adjusted EBITDA of $112.7 million and a 42% adjusted EBITDA margin.
  • The company is raising its full fiscal year 2025 guidance, with total revenue now expected to be between $1.085 billion and $1.093 billion and adjusted EBITDA between $451 million and $455 million.
  • CEO Matt Hawkins stated that Waystar delivered "another quarter of double-digit revenue growth and strong margins, outpacing our guidance on both measures," and highlighted the ongoing integration of Iodine Software to enhance its AI-powered platform.
Oct 29, 2025, 8:05 PM
Waystar Reports Third Quarter 2025 Results and Raises Full-Year Guidance
WAY
Earnings
Guidance Update
  • Waystar reported revenue of $268.7 million for Q3 2025, marking a 12% year-over-year increase, with net income of $30.6 million and non-GAAP net income of $67.8 million.
  • The company achieved a net income margin of 11% and an adjusted EBITDA margin of 42% in the third quarter of 2025.
  • Waystar is raising its full fiscal year 2025 guidance, with total revenue now expected to be between $1.085 billion and $1.093 billion, and adjusted EBITDA projected to be between $451 million and $455 million.
  • CEO Matt Hawkins noted double-digit revenue growth and strong margins, attributing confidence in the raised full-year guidance to continuing demand and focused execution, including the integration of Iodine Software.
Oct 29, 2025, 8:02 PM
Waystar Completes Acquisition of Iodine Software
WAY
M&A
New Projects/Investments
  • Waystar Holding Corp. completed the acquisition of Iodine Software on October 1, 2025.
  • The acquisition expands Waystar's total addressable market by over 15% and is expected to be immediately accretive to gross margin and adjusted EBITDA margin.
  • The acquisition is also anticipated to be accretive to revenue growth and non-GAAP net income per diluted share in 2027.
  • The consideration for the acquisition was approximately $458,598,269.88 in cash and 16,639,906 shares of Waystar Common Stock, with each share valued at $37.31.
Oct 1, 2025, 12:56 PM

Quarterly earnings call transcripts for Waystar Holding.

Let Fintool AI Agent track Waystar Holding's earnings for you

Get instant analysis when filings drop